Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Flagship Pioneering
Biotech
ProFound forms $35M preeclampsia pact with Gates Foundation
The biotech will use its vast repository of proteomics data to scour placental tissue for potential biomarkers and drug targets for preeclampsia.
Darren Incorvaia
Aug 27, 2026 6:30am
Former Legend CEO lands at K2—Chutes & Ladders
Aug 14, 2026 8:30am
Flagship inks deal with Saudi sovereign wealth fund company
Jun 24, 2026 8:24am
Boston, China and the future of biotech
May 29, 2026 9:09am
New Flagship biotech circles in on new DNA drug class
Apr 21, 2026 6:30am
Merck hands over $20M in IBD target deal with Quotient
Mar 24, 2026 6:00am
